Funding Opportunities

• Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp)
  (PA-18-314)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Institute for Occupational Safety and Health
  National Center for Emerging and Zoonotic Infectious Diseases
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): December 18, 2017, by 5:00 PM local time of applicant organization.
• Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
  (PA-18-322)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
  (PA-18-323)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28)
  (PAR-17-305)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): December 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
  (PAR-17-306)
  Office of Disease Prevention
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): New applications: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; October 5, 2020, by 5:00 PM local time of applicant organization. Resubmission applications: March 5, 2018; November 5, 2018; July 5, 2019; March 5, 2020; November 5, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
  (PAR-18-307)
  Office of Disease Prevention
  Application Receipt Date(s): New applications: February 16, 2018; October 16, 2018; June 16, 2019; February 16, 2020; October 16, 2020, by 5:00 PM local time of applicant organization. Resubmission applications: March 16, 2018; November 16, 2018; July 16, 2019; March 16, 2020; November 16, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed
  (PAR-18-310)
  National Cancer Institute
  Application Receipt Date(s): February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
  (PAR-18-313)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
  (PAR-18-317)
  National Cancer Institute
  Application Receipt Date(s): February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
  (PAR-18-319)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): March 13, 2018; March 13, 2019; March 13, 2020 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54)
  (RFA-CA-17-032)
  National Cancer Institute
  Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)
  (RFA-CA-17-033)
  National Cancer Institute
  Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
• Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01)
  (RFA-CA-17-045)
  National Cancer Institute
  Application Receipt Date(s): January 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)
  (RFA-CA-17-046)
  National Cancer Institute
  Application Receipt Date(s): January 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24)
  (RFA-CA-17-047)
  National Cancer Institute
  Application Receipt Date(s): January 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24)
  (RFA-CA-17-048)
  National Cancer Institute
  Application Receipt Date(s): January 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-EB-17-005)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): December 15, 2017; September 4, 2018; September 3, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.